Healthcare provider profile · identity verified

Daniel North, DO

Family Practice · KENNEBUNK, ME · NPI 1154826725

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	503	147
Lisinopril	Lisinopril	267	85
Levothyroxine Sodium	Levothyroxine Sodium	259	79
Amlodipine Besylate	Amlodipine Besylate	258	89
Losartan Potassium	Losartan Potassium	180	58
Rosuvastatin Calcium	Rosuvastatin Calcium	180	61
Omeprazole	Omeprazole	163	62
Metoprolol Succinate	Metoprolol Succinate	142	44
Hydrochlorothiazide	Hydrochlorothiazide	113	41
Tamsulosin Hcl	Tamsulosin Hcl	110	39
Albuterol Sulfate Hfa	Albuterol Sulfate	108	53
Sertraline Hcl	Sertraline Hcl	108	34
Simvastatin	Simvastatin	104	34
Metformin Hcl	Metformin Hcl	98	27
Metformin Hcl Er	Metformin Hcl	83	25
Famotidine	Famotidine	76	20
Gabapentin	Gabapentin	73	34
Furosemide	Furosemide	72	28
Eliquis	Apixaban	66	21
Bupropion Xl	Bupropion Hcl	62	23
Atenolol	Atenolol	61	19
Metoprolol Tartrate	Metoprolol Tartrate	61	20
Alendronate Sodium	Alendronate Sodium	59	20
Montelukast Sodium	Montelukast Sodium	59	17
Alprazolam	Alprazolam	58	13
Pantoprazole Sodium	Pantoprazole Sodium	54	19
Prednisone	Prednisone	54	39
Allopurinol	Allopurinol	51	17
Chlorthalidone	Chlorthalidone	51	15
Fluoxetine Hcl	Fluoxetine Hcl	44	11
Escitalopram Oxalate	Escitalopram Oxalate	43	17
Ozempic	Semaglutide	42	14
Trazodone Hcl	Trazodone Hcl	41	21
Pravastatin Sodium	Pravastatin Sodium	39	12
Carvedilol	Carvedilol	38	14
Citalopram Hbr	Citalopram Hydrobromide	38	11
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Mirtazapine	Mirtazapine	37	12
Lorazepam	Lorazepam	36	13
Fluticasone Propionate	Fluticasone Propionate	34	14
Glipizide Er	Glipizide	34	suppressed
Clonazepam	Clonazepam	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	18
Buspirone Hcl	Buspirone Hcl	31	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	18
Telmisartan	Telmisartan	27	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	11
Ezetimibe	Ezetimibe	21	suppressed
Spironolactone	Spironolactone	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Finasteride	Finasteride	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Azithromycin	Azithromycin	14	13
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error